World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
12855
World Ranking
3008
National Ranking
1196

Overview

Keith Henry is affiliated with Hennepin County Medical Center in the United States. Their research primarily focuses on the field of Medicine, with a notably strong emphasis on Infectious Diseases. Additional subfields of study include Epidemiology, Virology, Emergency Medicine, and General Health Professions.

The major topics addressed in their work revolve around HIV/AIDS, including research and interventions, drug development and treatment, and HIV-related health complications. Other specific topics include Pneumocystis jirovecii pneumonia detection and treatment, as well as Hepatitis C virus research.

Henry has published extensively within several scientific journals. Frequent publication venues for their work include Journal Watch, Open Forum Infectious Diseases, UNC Libraries, Open Journal of Clinical and Medical Case Reports, and Cureus.

Their recent notable papers include:

  • Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021, The Lancet HIV)
  • Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection (2023, NEJM Evidence)
  • Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria (2021, AIDS)
  • Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America (2020, UNC Libraries)
  • 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine (2020, Open Forum Infectious Diseases)

Collaborations are a component of Henry's research activities, with frequent coauthors including Peter Ruane, Onyema Ogbuagu, David M. Asmuth, Richard Gilson, and Jason Brunetta. These collaborations appear across multiple studies and publications.

Best Publications

  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

    Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner

  • Severe premature coronary artery disease with protease inhibitors

    Keith Henry;Holly Melroe;Jacquelyn Huebsch;Jessica Hermundson

  • Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

    Winston Cavert;Daan W. Notermans;Katherine Staskus;Stephen W. Wietgrefe

  • Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

    Edwin DeJesus;Jürgen K. Rockstroh;Keith Henry;Jean Michel Molina

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

    Alejo Erice;Douglas L. Mayers;David G. Strike;Kim J. Sannerud

  • Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

    Keith Henry;Holly Melroe;Jacquelyn Huebesch;Jessica Hermundson

  • Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection

    Zhi Qiang Zhang;Daan W. Notermans;Gerald Sedgewick;Winston Cavert

  • Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

    Keith Henry;Herbert Cantrill;Courtney Fletcher;Barbara J. Chinnock

  • Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

    Jean Michel Molina;Bonaventura Clotet;Jan van Lunzen;Adriano Lazzarin

  • Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

    Herbert L. Cantrill;Keith Henry;N. Holly Melroe;William H. Knobloch

  • Indinavir concentrations and antiviral effect.

    Edward P. Acosta;Keith Henry;Leslie Baken;Linda M. Page

  • Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

    Pablo Tebas;Amy K. Patick;Ellen M. Kane;Michael K. Klebert

  • Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

    Mark Nelson;Keikawus Arastéh;Bonaventura Clotet;David A. Cooper

  • High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

    Kristin E. Mondy;John Gottdiener;E. Turner Overton;Keith Henry

  • Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010

    Kate Buchacz;Bryan Lau;Yuezhou Jing;Ronald Bosch

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy.

    Richard W. Price;Constantin T. Yiannoutsos;David B. Clifford;Lawrence Zaborski

  • Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

    Courtney V. Fletcher;Peter L. Anderson;Thomas N. Kakuda;Timothy W. Schacker

  • Risk of cancers during interrupted antiretroviral therapy in the SMART study.

    Michael J Silverberg;Jacqueline Neuhaus;Mark Bower;Daniela Gey

  • Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases

    Jason V. Baker;Jason V. Baker;Grace Peng;Joshua Rapkin;David Krason

  • Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

    J B Jackson;S Y Kwok;J J Sninsky;J S Hopsicker

  • High-Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection

    Jason Baker;Woubeshet Ayenew;Woubeshet Ayenew;Harrison Quick;Katherine Huppler Hullsiek

Frequent Co-Authors

John T. Brooks
John T. Brooks Centers for Disease Control and Prevention
Pragna Patel
Pragna Patel Centers for Disease Control and Prevention
Henry H. Balfour
Henry H. Balfour University of Minnesota
Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
Pablo Tebas
Pablo Tebas University of Pennsylvania
William G. Powderly
William G. Powderly Washington University in St. Louis
Elizabeth R. Unger
Elizabeth R. Unger Centers for Disease Control and Prevention
James D. Neaton
James D. Neaton University of Minnesota
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths that extend beyond traditional laboratory roles. For those interested in healthcare, pursuing an online health information management program offers a promising route. Many of these programs are online health information management programs cahiim accredited, ensuring quality education aligned with industry standards.

Graduates with expertise in health information management can explore careers as health information managers, a role valued for its critical function in managing patient data and healthcare systems. The healthcare information management salary is competitive, reflecting the growing demand for skilled professionals in this space.

Alternatively, those interested in clinical practice might consider becoming a functional medicine nurse. This specialization focuses on holistic patient care and requires advanced training. For more insight, explore the pathway to become a functional medicine nurse.

Additionally, careers in medical coding provide an essential backbone for healthcare administration. Certified professionals benefit from stable employment and lucrative pay. Learn more about the cpc medical coding salary and career opportunities to evaluate if this path suits your goals.

Best Scientists Citing Keith Henry

Trending Scientists

Recently Published Articles